Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Researchers developed a clustered regularly interspaced short palindromic repeats-based diagnostic technique for detecting SARS-CoV-2 RNA.

21 Apr 2022

Physical and mental characteristics post-COVID-19 infection

Researchers conducted symptom assessment, cognitive tests, and physical measurements after COVID-19 infections.

21 Apr 2022

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Researchers investigated the interplay of all the factors responsible for within-host evolution of SARS-CoV-2 variants in immunocompromised patients.

21 Apr 2022

Association between SARS-CoV-2 Omicron viral load and vaccination history

Researchers analyzed the association between viral loads in SARS-CoV-2 Omicron variant infection and vaccination history.

21 Apr 2022

Judge’s ruling on the CDC mask mandate highlights the limits of the agency’s power

The role that the federal government plays in containing future epidemics will hinge on the outcome of an appeal of this week's court ruling that overturned the mask mandate for travelers on airlines, trains, and the nation's mass transit systems.

21 Apr 2022

Anti-vaccine ideology gains ground as lawmakers seek to erode rules for kids’ shots

Not long ago, Kansas showed strong bipartisan support for vaccines as a tool to support a robust public health system.

21 Apr 2022

Evolution of SARS-CoV-2 variants

Research has demonstrated the evolutionary process and biology of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic.

21 Apr 2022

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers investigated the effect of binding antibodies on SARS-CoV-2 Omicron breakthrough infections.

21 Apr 2022

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

In a new study, risk assessments for research, survey, monitoring, management, wildlife rehabilitation, and wildlife control were updated regarding SARS-CoV-2.

21 Apr 2022

Study evaluates the use of a diagnostic code for Long COVID

Researchers evaluated the use of U09.9, a CD-10-CM code described as 'Post coronavirus disease 2019 (COVID-19) condition, unspecified' for post-acute COVID-19 sequelae (long COVID).

21 Apr 2022

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Researchers surveyed over 360 COVID-19 patients to characterize the SARS-CoV-2 genomic sequence diversity of individual infections.

21 Apr 2022

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice.

21 Apr 2022

Revolutionary mRNA vaccine technology: History, facts and the future

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with the burden of the world’s most deadly infectious diseases.

20 Apr 2022

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

A study released in JAMA Network Open by investigators at Providence, one of the largest health systems in the United States, and the University of Chicago, found that the level of protection granted by a prior symptomatic COVID-19 infection among unvaccinated individuals was on par with the level of protection provided by mRNA vaccines, with natural immunity providing a longer window of protection than mRNA vaccines.

20 Apr 2022

RNA splicing abnormalities in COVID-19 patients

This study entailed the integration of multiple-omics datasets to examine the dysregulation in the host splicing mechanism and alteration in protein isoforms among COVID-19 patients.

20 Apr 2022

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

A recent study has revealed a full cycle of substrate cleavage for the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – providing, in turn, a steadfast foundation for developing potent new viral inhibitors. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS).

20 Apr 2022

Study examines vitamin D and COVID-19 media coverage in the U.K.

A new study investigates the relationship between COVID-19 and vitamin D that has been presented in traditional media sources like U.K. newspapers.

20 Apr 2022

Advancements in HIV science

As far as viruses go, human immunodeficiency virus (HIV) is quite simple. About 100,000 times smaller than a red blood cell, the virus expresses just a dozen proteins, yet it can establish a lifelong infection that, if left untreated, causes acquired immunodeficiency syndrome (AIDS) and death.

20 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Six salivary ELISAs were developed to evaluate the immune response to SARS-CoV-2 and estimate rates of past infection.

20 Apr 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Physical and mental characteristics post-COVID-19 infection

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Association between SARS-CoV-2 Omicron viral load and vaccination history

Judge’s ruling on the CDC mask mandate highlights the limits of the agency’s power

Anti-vaccine ideology gains ground as lawmakers seek to erode rules for kids’ shots

Evolution of SARS-CoV-2 variants

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

Study evaluates the use of a diagnostic code for Long COVID

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Revolutionary mRNA vaccine technology: History, facts and the future

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

RNA splicing abnormalities in COVID-19 patients

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

Study examines vitamin D and COVID-19 media coverage in the U.K.

Advancements in HIV science

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in